Literature DB >> 17442975

Scavenger Receptors SR-AI/II and MARCO limit pulmonary dendritic cell migration and allergic airway inflammation.

Mohamed S Arredouani1, Francesca Franco, Amy Imrich, Alexey Fedulov, Xin Lu, David Perkins, Raija Soininen, Karl Tryggvason, Steven D Shapiro, Lester Kobzik.   

Abstract

The class A scavenger receptors (SR-A) MARCO and SR-AI/II are expressed on lung macrophages (MPhis) and dendritic cells (DCs) and function in innate defenses against inhaled pathogens and particles. Increased expression of SR-As in the lungs of mice in an OVA-asthma model suggested an additional role in modulating responses to an inhaled allergen. After OVA sensitization and aerosol challenge, SR-AI/II and MARCO-deficient mice exhibited greater eosinophilic airway inflammation and airway hyperresponsiveness compared with wild-type mice. A role for simple SR-A-mediated Ag clearance ("scavenging") by lung MPhis was excluded by the observation of a comparable uptake of fluorescent OVA by wild-type and SR-A-deficient lung MPhis and DCs. In contrast, airway instillation of fluorescent Ag revealed a significantly higher traffic of labeled DCs to thoracic lymph nodes in SR-A-deficient mice than in controls. The increased migration of SR-A-deficient DCs was accompanied by the enhanced proliferation in thoracic lymph nodes of adoptively transferred OVA-specific T cells after airway OVA challenge. The data identify a novel role for SR-As expressed on lung DCs in the down-regulation of specific immune responses to aeroallergens by the reduction of DC migration from the site of Ag uptake to the draining lymph nodes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17442975     DOI: 10.4049/jimmunol.178.9.5912

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  29 in total

Review 1.  Enhancement of dendritic cells as vaccines for cancer.

Authors:  Meghan E Turnis; Cliona M Rooney
Journal:  Immunotherapy       Date:  2010-11       Impact factor: 4.196

2.  Is the scavenger receptor MARCO a new immune checkpoint?

Authors:  Mohamed S Arredouani
Journal:  Oncoimmunology       Date:  2014-12-15       Impact factor: 8.110

3.  Engineering Immunological Tolerance Using Quantum Dots to Tune the Density of Self-Antigen Display.

Authors:  Krystina L Hess; Eunkeu Oh; Lisa H Tostanoski; James I Andorko; Kimihiro Susumu; Jeffrey R Deschamps; Igor L Medintz; Christopher M Jewell
Journal:  Adv Funct Mater       Date:  2017-04-03       Impact factor: 18.808

4.  Housing conditions modulate the severity of Mycoplasma pulmonis infection in mice deficient in class A scavenger receptor.

Authors:  Jennifer L Booth; Todd M Umstead; Sanmei Hu; Kevin F Dybvig; Timothy K Cooper; Ronald P Wilson; Zissis C Chroneos
Journal:  Comp Med       Date:  2014-12       Impact factor: 0.982

5.  Therapeutic inflammatory monocyte modulation using immune-modifying microparticles.

Authors:  Daniel R Getts; Rachael L Terry; Meghann Teague Getts; Celine Deffrasnes; Marcus Müller; Caryn van Vreden; Thomas M Ashhurst; Belal Chami; Derrick McCarthy; Huiling Wu; Jin Ma; Aaron Martin; Lonnie D Shae; Paul Witting; Geoffrey S Kansas; Joachim Kühn; Wali Hafezi; Iain L Campbell; David Reilly; Jana Say; Louise Brown; Melanie Y White; Stuart J Cordwell; Steven J Chadban; Edward B Thorp; Shisan Bao; Stephen D Miller; Nicholas J C King
Journal:  Sci Transl Med       Date:  2014-01-15       Impact factor: 17.956

6.  Intranasal CpG therapy attenuated experimental fungal asthma in a TLR9-dependent and -independent manner.

Authors:  Hemanth Ramaprakash; Cory M Hogaboam
Journal:  Int Arch Allergy Immunol       Date:  2009-12-16       Impact factor: 2.749

7.  Targeting MARCO can lead to enhanced dendritic cell motility and anti-melanoma activity.

Authors:  Norimasa Matsushita; Hiroshi Komine; Annabelle Grolleau-Julius; Shari Pilon-Thomas; James J Mulé
Journal:  Cancer Immunol Immunother       Date:  2010-01-08       Impact factor: 6.968

8.  Microparticles bearing encephalitogenic peptides induce T-cell tolerance and ameliorate experimental autoimmune encephalomyelitis.

Authors:  Daniel R Getts; Aaron J Martin; Derrick P McCarthy; Rachael L Terry; Zoe N Hunter; Woon Teck Yap; Meghann Teague Getts; Michael Pleiss; Xunrong Luo; Nicholas J C King; Lonnie D Shea; Stephen D Miller
Journal:  Nat Biotechnol       Date:  2012-11-18       Impact factor: 54.908

9.  High-mobility group box 1 contributes to lethality of endotoxemia in heme oxygenase-1-deficient mice.

Authors:  Rina Takamiya; Chi-Chih Hung; Sean R Hall; Koichi Fukunaga; Takashi Nagaishi; Toshitaka Maeno; Caroline Owen; Alvaro A Macias; Laura E Fredenburgh; Akitoshi Ishizaka; Richard S Blumberg; Rebecca M Baron; Mark A Perrella
Journal:  Am J Respir Cell Mol Biol       Date:  2008-12-18       Impact factor: 6.914

Review 10.  Metal Nanomaterial Toxicity Variations Within the Vascular System.

Authors:  Alaeddin B Abukabda; Phoebe A Stapleton; Timothy R Nurkiewicz
Journal:  Curr Environ Health Rep       Date:  2016-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.